Curaleaf Celebrates Launch of Adult-Use Sales in Maine at Bangor Dispensary

The opening marks the Company's only adult-use location in Maine

STAMFORD, Conn., Jan. 21, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of an adult-use store adjacent to the medical dispensary located at 829 Hogan Rd., Bangor, Maine. With this opening, Curaleaf expands to five retail locations in Maine, and 161 nationwide.

Conveniently situated near the Bangor Mall, hotels, and restaurants, Curaleaf Bangor (829 Hogan Road, Unit 38) has served medical cannabis patients since 2021. The medical store has been upgraded and the new adult-use store at Unit 46 offers high quality cannabis products to consumers over the age of 21. Both stores will operate Monday through Sunday from 10:00 AM to 8:00 PM ET.

Customers can explore Curaleaf's full portfolio of high-quality cannabis products across flower, pre-rolls, vapes, and edibles, including Grassroots Dark Heart Collection flower, Find Flower & Pre-Rolls, Select BRIQ all-in-one vapes, and B Noble pre-rolls. The expanded product assortment is designed to meet the needs of both long-time medical patients and first-time adult-use consumers seeking a trusted, educational retail experience.

"Each new milestone in our retail footprint reflects Curaleaf's mission to expand access to high-quality, tested, legal cannabis," said Boris Jordan, Curaleaf Chairman and CEO. "We're proud to welcome adult-use customers in Bangor while continuing to support Maine's medical community with best-in-class products, expert guidance, and a customer-first experience."

Curaleaf remains committed to serving Maine's medical cannabis community through our medical dispensaries in Bangor, Ellsworth, Auburn and Wells, offering dedicated patient resources and a full menu of products, patient discounts, and personalized guidance from trained team members.

For more information on Curaleaf's locations, patient resources, and product portfolio in Maine, please visit https://curaleaf.com/dispensary/maine.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the transitioning of a dispensary in Bangor, Maine. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
[email protected] 

Media Contact:
MATTIO Communications
[email protected] 

SOURCE Curaleaf Holdings, Inc.